Genetic testing for familial hypercholesterolemia—past, present, and future
Open Access
- 16 October 2021
- journal article
- review article
- Published by Elsevier BV in Journal of Lipid Research
- Vol. 62, 100139
- https://doi.org/10.1016/j.jlr.2021.100139
Abstract
No abstract availableKeywords
This publication has 84 references indexed in Scilit:
- Analysis of the frequency and spectrum of mutations recognised to cause familial hypercholesterolaemia in routine clinical practice in a UK specialist hospital lipid clinicAtherosclerosis, 2013
- Identification and biochemical analysis of a novel APOB mutation that causes autosomal dominant hypercholesterolemiaMolecular Genetics & Genomic Medicine, 2013
- Use of targeted exome sequencing as a diagnostic tool for Familial HypercholesterolaemiaJournal of Medical Genetics, 2012
- Description of a Large Family with Autosomal Dominant Hypercholesterolemia Associated with theAPOEp.Leu167del MutationHuman Mutation, 2012
- Genetic causes of familial hypercholesterolaemia in patients in the UK: relation to plasma lipid levels and coronary heart disease riskJournal of Medical Genetics, 2006
- Mutations in PCSK9 cause autosomal dominant hypercholesterolemiaNature Genetics, 2003
- The Molecular Mechanism for the Genetic Disorder Familial Defective Apolipoprotein B100Online Journal of Public Health Informatics, 2001
- Familial Hypercholesterolemia in the Finnish North KareliaArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- Independent Mutations at Codon 3500 of the Apolipoprotein B Gene Are Associated With HyperlipidemiaArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Deletion in the Gene for the Low-Density-Lipoprotein Receptor in a Majority of French Canadians with Familial HypercholesterolemiaThe New England Journal of Medicine, 1987